Influence of toremifene on the endocrine regulation in breast cancer patients
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (2) , 154-158
- https://doi.org/10.1016/0959-8049(94)90077-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Phase II trials with toremifene in advanced breast cancer: A reviewBreast Cancer Research and Treatment, 1990
- Safety and efficacy of toremifene in breast cancer patients. A phase II studyJournal of Steroid Biochemistry, 1990
- Effect of toremifene in breast cancer patients. Preliminary communicationJournal of Steroid Biochemistry, 1990
- Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II studyEuropean Journal of Cancer and Clinical Oncology, 1988
- Hormonal Changes during a Prolonged Tamoxifen Treatment in Patients with Advanced Breast CancerOncology, 1986
- Oestrogen-like effects of tamoxifen on the concentration of proteins in plasmaActa Endocrinologica, 1981
- INCREASES IN STEROID BINDING GLOBULINS INDUCED BY TAMOXIFEN IN PATIENTS WITH CARCINOMA OF THE BREASTJournal of Endocrinology, 1978
- Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course.BMJ, 1977
- EFFECT OF THE ANTI-OESTROGEN TAMOXIFEN ON PLASMA LEVELS OF LUTEINIZING HORMONE, FOLLICLE-STIMULATING HORMONE, PROLACTIN, OESTRADIOL AND PROGESTERONE IN NORMAL PRE-MENOPAUSAL WOMENJournal of Endocrinology, 1976
- INHIBITION OF OESTROGEN-STIMULATED PROLACTIN RELEASE BY ANTI-OESTROGENSJournal of Endocrinology, 1975